Lynparza Olaparib Tablets Reference Listed Drug

* Please be kindly noted products are supplied for RLD supplies/ Reference listed drugs/ Comparator Drug Clinical trials. We do not sell to patients.

 

Generic name	Olaparib Tablets
Trade name	Lynparza
Specification	100mg,150mg
Main ingredients	Olaparib
Appearance	150mg: green to green/grey, oval, double convex, engraved "OP150" on one side, blank on the other. 100mg: yellow to dark yellow, oval, double convex, one side engraved with "OP100, the other side blank
Manufacturer	AbbVie Limited

Indications: 

Used for maintenance therapy for newly diagnosed adults with germline or somatic BRCA mutations (gBRCAm or sBRCAm) of advanced epithelial ovarian, fallobal, or primary peritoneal cancer after complete or partial response to first-line platinum-based chemotherapy.

Maintenance therapy in adults with platinum-sensitive recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer after complete or partial response to platinum-containing chemotherapy.

For more details,pls contact Janney:

Email: tosun-global@upharm.cn

Wechat/Whatsapp:(+86)18922120575

Hot Tags: Lynparza Olaparib Tablets Reference Listed Drug, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Acarbose Tablets, Phenytoin Sodium Tablets, AdapaleneGel, Argatroban Injection, Bimatoprost Ophthalmic, Esomeprazole Magnesium Enteric Coated Capsules

• Previous: Luvox Fluvoxamine Maleate Tablets Reference Listed Drug
• Next: Avastin Bevacizumab Injection Reference Listed Drug